Peptide Comparison
CerebrolysinvsSemax
Porcine brain-derived neuropeptide preparation containing bioactive peptide fragments of neurotrophic factors, used clinically in over 40 countries for stroke recovery, traumatic brain injury, and cognitive impairment
A brain-boosting peptide that supercharges your cognitive function by ramping up BDNF—the protein your neurons need to grow, connect, and stay sharp—all delivered through a simple nasal spray.
At a Glance
Quick
comparison
Dose Range
Cerebrolysin
5–50 ml
Semax
200–900 mcg
Frequency
Cerebrolysin
Once daily
Semax
Once daily
Administration
Cerebrolysin
Intravenous (IV) injection or infusion
Semax
Intranasal spray
Cycle Length
Cerebrolysin
8-12 weeks
Semax
4-6 weeks
Onset Speed
Cerebrolysin
Moderate (1-2 weeks)
Semax
Rapid (hours to days)
Evidence Level
Cerebrolysin
Moderate human trials (Phase 1-2)
Semax
Moderate human trials (Phase 1-2)
Efficacy
Benefit
ratings
Stroke Recovery
Alzheimer's Support
Brain Injury Healing
Cognitive Enhancement
Neuroprotection
Mental Energy
Technical Data
Compound
specifications
Cerebrolysin
Molecular Formula
Complex mixture — no single molecular formula (contains multiple peptide fragments and free amino acids derived from porcine brain proteins)
Molecular Weight
Bioactive peptide components are all below 10 kDa (10,000 Da); the preparation contains a spectrum of peptide sizes
Half-Life
Approximately 15-30 minutes (IV administration)
Bioavailability
~85-100% (intramuscular injection)
CAS Number
Not assigned (biological mixture)
Semax
Molecular Formula
C37H51N9O10S
Molecular Weight
813.9 g/mol
Half-Life
Several minutes to hours (intranasal effects persist longer)
Bioavailability
High via intranasal route (directly reaches brain)
CAS Number
80714-61-0
Protocols
Dosing
tiers
Cerebrolysin
Semax
Applications
Best
suited for
Cerebrolysin
Post-stroke neurorecovery and rehabilitation support
Cerebrolysin is particularly well-suited for individuals focused on post-stroke neurorecovery and rehabilitation support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Cognitive support in Alzheimer's disease and vascular dementia
Cerebrolysin is particularly well-suited for individuals focused on cognitive support in alzheimer's disease and vascular dementia. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Traumatic brain injury recovery and neuroprotection
Cerebrolysin is particularly well-suited for individuals focused on traumatic brain injury recovery and neuroprotection. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Age-related cognitive decline and mild cognitive impairment
Cerebrolysin is particularly well-suited for individuals focused on age-related cognitive decline and mild cognitive impairment. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Semax
Students and Knowledge Workers
If your day revolves around learning, studying, or processing complex information, Semax can be a game-changer. It enhances memory consolidation and recall while improving your ability to focus for extended periods—perfect for exam prep or demanding projects.
Those Seeking Mental Clarity
Brain fog? Semax works by boosting BDNF—the protein that helps neurons communicate effectively. Users often report feeling like the 'mental static' clears away, leaving sharper, more efficient thinking in its place.
Neuroprotection Seekers
Beyond immediate cognitive benefits, Semax offers protective effects for your brain cells. It acts as an antioxidant (especially against copper toxicity) and supports neuronal health—valuable for anyone concerned about long-term brain wellness.
Recovery Support (Under Medical Supervision)
In Russia, Semax is approved for helping stroke patients and those with traumatic brain injuries recover cognitive function. While not FDA-approved for this use elsewhere, the research shows meaningful neuroprotective and neurorestorative properties.
Safety Profile
Side
effects
Cerebrolysin
Common
- Injection site reactions
- Headache
- Dizziness and vertigo
- Nausea and gastrointestinal discomfort
- Agitation or restlessness
- Fever
Uncommon
- Allergic reaction
Serious
- Severe hypersensitivity reaction
Semax
Common
- Nasal irritation
- Mild headache
- Increased alertness
Uncommon
- Temporary blood pressure increase
- Dizziness
Serious
- Allergic reaction
Research Status
Safety
& evidence
Cerebrolysin
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
Cerebrolysin is an FDA-unregulated neuroprotective agent consisting of porcine brain-derived peptides and amino acids that has been used primarily in Eastern Europe and Asia. Safety data is limited to observational clinical use and small open-label trials rather than rigorous randomized controlled trials with formal safety monitoring. As a complex mixture of undefined peptide fragments from animal sources, batch consistency and sterility cannot be guaranteed without pharmaceutical manufacturing standards. Potential allergic reactions to porcine proteins and transmissible spongiform encephalopathy (TSE) risks from animal-derived components have not been adequately ruled out.
Contraindications
- xKnown hypersensitivity to Cerebrolysin or porcine-derived products
- xSevere renal impairment or renal failure
- xStatus epilepticus or uncontrolled epilepsy
- xPregnancy and breastfeeding — insufficient safety data
Semax
Evidence Level
Moderate human trials (Phase 1-2)
FDA Status
Research compound
Safety Overview
Semax has been used clinically in Russia for over 25 years with an excellent safety profile. It's approved there for treating stroke, cognitive impairment, and optic nerve diseases. Studies consistently show minimal side effects, mostly limited to mild nasal irritation when using the spray form. Unlike stimulants, Semax doesn't appear to cause tolerance, dependence, or withdrawal symptoms even with extended use.
Contraindications
- xPregnancy or planning to become pregnant
- xCurrently breastfeeding
- xHistory of seizures or epilepsy
- xKnown allergy to ACTH-related peptides
- xUncontrolled hypertension
Decision Guide
Which is
right for you?
Choose Cerebrolysin if...
- Post-stroke neurorecovery and rehabilitation support
- Cognitive support in Alzheimer's disease and vascular dementia
- Traumatic brain injury recovery and neuroprotection
- Age-related cognitive decline and mild cognitive impairment
Choose Semax if...
- Cognitive enhancement
- Memory improvement
- Focus and concentration
- Neuroprotection